Literature DB >> 33530201

Efficacy and safety of heat-sensitive moxibustion in the treatment of ulcerative colitis: A protocol for a systematic review and meta-analysis.

Jinlong Wang1, Quanhui Zhang2, Yongwen Deng1, Gen Deng1, Feihong Huang1, Yiduo Zhou1, Mingyan Jia1, Haoran Yi1.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is a chronic nonspecific intestinal inflammatory disease with unclear etiology occurring in the colonic mucosa. Its clinical manifestations are characterized by recurrent abdominal pain, diarrhea, mucous pus, and blood stool. The severity of the disease varies, and itis characterized by a high recurrence rate. Because of its long course of disease, easy to relapse, protracted and difficult to recover, seriously affect the quality of life, increase the economic burden of patients and society, and even the risk of developing cancer, it has become one of the hot issues of general concern in the medical field. Heat-sensitive moxibustion therapy has shown strong advantages in the treatment of UC, and the curative effect is accurate. therefore, this paper will carry out a systematic evaluation and meta analysis of the efficacy and safety of heat-sensitive moxibustion in the treatment of UC.
METHODS: We will be searching 8 electronic databases, including PubMed, Embase, Web of Science, Cochrane Library, the China National Knowledge Infrastructure, Chinese Science and Technology Periodical Database, Wanfang Database, and Chinese Biomedical Literature Database. We will search above electronic databases from the beginning to December 2020, without any language restriction. Clinical efficacy, including total effective rate or cure rate, clinical symptom integral (abdominal pain, diarrhea, purulent stool), and recurrence rate will be accepted as the primary outcomes. The changes of cytokine Hs-CRP, IL-6, TNF-αlevels in serum, and improvement of colorectal mucosa will be used as secondary outcomes. RevMan 5.3 software will be used for statistical analysis. The result about the curative effect and safety of heat-sensitive moxibustion for UC will be presented as risk ratio for dichotomous data and mean differences with a 95% confidence interval for continuous data.
RESULTS: When this research program is completed, the relevant results can be obtained.
CONCLUSIONS: The results of this study will provide reliable evidence for the efficacy and safety of heat-sensitive moxibustion in the treatment of UC. INPLASY REGISTRATION NUMBER: INPLASY20201101034.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33530201      PMCID: PMC7850641          DOI: 10.1097/MD.0000000000024078

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  4 in total

1.  [Paying attention to the heat thermal sensitivity of moxibustion is the key for raising the curative effect].

Authors:  Ri-Xin Chen; Ming-Ren Chen; Ming-Fei Kang; Zhen-Hai Chi; Bo Zhang
Journal:  Zhen Ci Yan Jiu       Date:  2010-08

2.  [Key point of moxibustion, arrival of qi produces curative effect].

Authors:  Ri-xin Chen; Ming-fei Kang
Journal:  Zhongguo Zhen Jiu       Date:  2008-01

3.  Inflammatory bowel disease in the 21(st) century in China: turning challenges into opportunities.

Authors:  Qin Ouyang; Lin Yun Xue
Journal:  J Dig Dis       Date:  2012-04       Impact factor: 2.325

Review 4.  Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.

Authors:  Bao-Jian Guo; Zhao-Xiang Bian; Hong-Cong Qiu; Yi-Tao Wang; Ying Wang
Journal:  Ann N Y Acad Sci       Date:  2017-08       Impact factor: 5.691

  4 in total
  2 in total

1.  DNMT3a-Mediated Enterocyte Barrier Dysfunction Contributes to Ulcerative Colitis via Facilitating the Interaction of Enterocytes and B Cells.

Authors:  Bo Cheng; Ai-Mei Rong; Wenlu Li; Xiuqian Bi; Xinguang Qiu
Journal:  Mediators Inflamm       Date:  2022-05-06       Impact factor: 4.529

2.  Gut microbiome alterations in colitis rats after moxibustion at bilateral Tianshu acupoints.

Authors:  Qin Qi; Ya-Nan Liu; Si-Yi Lv; Huan-Gan Wu; Lin-Shuang Zhang; Zhan Cao; Hui-Rong Liu; Xiao-Mei Wang; Lu-Yi Wu
Journal:  BMC Gastroenterol       Date:  2022-02-12       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.